Clinical Trial Office

The DKFZ Clinical Trial Office (CTO) was founded in April 2018 to generate a strategic portfolio of clinical trials and data by enabling the performance of high-quality clinical trials under formal sponsorship of DKFZ. The CTO's main tasks are the establishment and implementation of structures and processes to ensure DKFZ's sponsor oversight in the start-up and conduction phase of clinical drug trials. In addition, the CTO is responsible for the scientific and administrative framework needed to support clinical research at DKFZ.

CTO advises scientists during the start-up phase of a clinical drug trial and coordinates the application for DKFZ's sponsorship. After a formal application for sponsorship, the CTO will initiate an internal review process and advise the management board in its decision to accept the sponsorship for a given clinical drug trial. During the preparation and conduct of a clinical trial, the CTO acts as the prime contact person for sponsor issues and oversees sponsor oversight activities.


Dr. Julia Ritzerfeld (Head)
Tel: 06221-42 1678

to top
powered by webEdition CMS